SEC Form 4 · accession 0000899243-15-010395
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Eleanor Ramos
Officer — Chief Medical Officer
Period of report
Aug 17, 2015
Accepted (ET)
Dec 23, 2015 · 8:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2015 | P | 10,000 | $20.00 | A | 10,000 | D | |
| Common Stock | Dec 22, 2015 | P | 1,000 | $30.28 | A | 11,000 | D |
Table II — derivative securities
No Table II lines on this filing.